A fresh suggestion to immunise all 20 million children between the ages of 6 months and 5 years old was made public on Saturday by CDC Director Rochelle Walensky. When testing effectiveness against moderate or severe COVID-19 infection, the trials were too small to establish statistical significance. In light of evidence from older children and adults, the FDA permitted both firms to extrapolate efficacy by measuring antibody levels.
In neither the vaccination group nor the placebo group were there any occurrences of severe COVID-19 disease. 4,774 youngsters received the Moderna vaccination, whereas 4,526 received the Pfizer vaccine. Based on 3 instances in the vaccination group and 7 cases in the placebo group in a subgroup of children, Pfizer found that their vaccine was 80% effective in avoiding symptomatic COVID-19.
Ironically, the vaccination group had higher general hospitalizations (unspecified). Six of the seven kids who needed to be hospitalised were in the vaccination group, and one was in the placebo group, which was only half as big.